Simple and Non-invasive Liver Fibrosis Stage Prediction Method

Evaluation of stage of liver fibrosis in chronic type C hepatitis is very important in patient therapy. Commonly used method for fibrosis stage determination is liver biopsy, but it is an invasive method and also single biopsy does not give the confidence thus it is required to retrieve samples from more than one region of liver [1]. Some non-invasive tests methods are also available, but are expensive due to requirement of using costly, specialized blood sample markers – such commercial methods like: FibroTest by BioPredictive [2] and ELF Test by Siemens [3]. This article describes a simple and non-expensive indirect fibrosis stage prediction method, based on a generic blood test results and also the research method for biomedical data analysis for creating such methods of prediction. The predicting formula or a classifier generated using presented method should be considered as an indirect fibrosis marker.